Michael Kaufmann Net Worth

The estimated Net Worth of Michael C Kaufmann is at least $20.5 Million dollars as of 25 January 2024. Mr. Kaufmann owns over 1,620 units of Cardinal Health stock worth over $1,407,580 and over the last 15 years he sold CAH stock worth over $4,858,626. In addition, he makes $14,217,100 as Chief Executive Officer and Director at Cardinal Health.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Kaufmann CAH stock SEC Form 4 insiders trading

Michael has made over 27 trades of the Cardinal Health stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,620 units of CAH stock worth $183,627 on 25 January 2024.

The largest trade he's ever made was exercising 388,995 units of Cardinal Health stock on 10 February 2014 worth over $11,280,855. On average, Michael trades about 7,579 units every 44 days since 2009. As of 25 January 2024 he still owns at least 12,418 units of Cardinal Health stock.

You can see the complete history of Mr. Kaufmann stock trades at the bottom of the page.

Michael Kaufmann biography

Michael C. Kaufmann serves as Chief Executive Officer, Director of the Company. He joined Cardinal Health in 1990 and has served as chief financial officer of the company since 2014. During that time, he has overseen all of the financial activities for the company including external reporting, investor relations, tax strategy/planning, and capital deployment as well as Global Sourcing for both the Pharmaceutical and Medical segments. During his 27 years at Cardinal Health, Kaufmann has served in a wide range of leadership positions across operations, sales and finance roles touching all areas of Cardinal Health. Kaufmann was instrumental in orchestrating key activities such as the joint venture with CVS Health that formed Red Oak Sourcing and the creation of Fuse, the Cardinal Health technology innovation center. Kaufmann serves as executive sponsor of the Cardinal Health Women's Initiative Network, an employee resource group with the goal to foster a culture of partnerships that makes Cardinal Health a suitable place for women to work and grow their careers. His support of women leaders in healthcare led to the Healthcare Businesswomen's Association naming Kaufmann as its 2012 "Honorable Mentor" and the Institute for Women's Leadership awarding him the 2014 "Guys Who Get it Award." He currently serves as a member of the board of directors for MSC Industrial Supply and on the executive board of Red Oak Sourcing. Kaufmann is a past member of the executive committee of both the Healthcare Distribution Management Association and the National Association of Chain Drug Stores. He also serves as a trustee atOhio Northern Universityand is an active member of the community. Prior to Cardinal Health, Kaufmann had a successful career in audit and consulting with Arthur Andersen, one of the nation's largest public accounting firms.

What is the salary of Michael Kaufmann?

As the Chief Executive Officer and Director of Cardinal Health, the total compensation of Michael Kaufmann at Cardinal Health is $14,217,100. There are no executives at Cardinal Health getting paid more.

How old is Michael Kaufmann?

Michael Kaufmann is 57, he's been the Chief Executive Officer and Director of Cardinal Health since 2019. There are 15 older and 9 younger executives at Cardinal Health. The oldest executive at Cardinal Health, Inc. is John Losh, 74, who is the Independent Director.

What's Michael Kaufmann's mailing address?

Michael's mailing address filed with the SEC is C/O MSC INDUSTRIAL DIRECT CO., INC., 515 BROADHOLLOW ROAD, MELVILLE, NY, 11747.

Insiders trading at Cardinal Health

Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett, and Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.

What does Cardinal Health do?

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Complete history of Mr. Kaufmann stock trades at Cardinal Health and MSC Industrial Direct Co

Cardinal Health executives and stock owners

Cardinal Health executives and other stock owners filed with the SEC include:

• Michael Kaufmann,
  Chief Executive Officer, Director
• Victor Crawford,
  Chief Executive Officer - Pharmaceutical Segment
• Jason Hollar,
  Chief Financial Officer
• Stephen Mason,
  Chief Executive Officer - Medical Segment
• Jessica Mayer,
  Chief Legal and Compliance Officer
• Michael C. Kaufmann,
  CEO & Director
• David Evans,
  Independent Director
• Victor L. Crawford,
  Chief Exec. Officer of Pharmaceutical Segment
• Jason M. Hollar,
  Chief Financial Officer
• Stephen M. Mason,
  Chief Exec. Officer of Medical Segment
• Jessica L. Mayer,
  Chief Legal & Compliance Officer
• Gregory Kenny,
  Independent Non-Executive Chairman of the Board
• Carrie Cox,
  Independent Director
• John Losh,
  Independent Director
• Bruce Downey,
  Independent Director
• Dean Scarborough,
  Independent Director
• Patricia Hemingway Hall,
  Independent Director
• John Weiland,
  Independent Director
• Calvin Darden,
  Independent Director
• Nancy Killefer,
  Independent Director
• Akhil Johri,
  Independent Director
• Sheri Edison,
  Independent Director
• Brian Rice,
  Executive Vice President, Chief Information Officer and Customer Support Services
• Ola Snow,
  Chief Human Resource Officer
• Dr. Michele A. M. Holcomb Ph.D.,
  Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer
• Brian S. Rice,
  Chief Information Officer, Exec. VP & Global Bus. Services
• Craig Cowman,
  Exec. VP of Global Sourcing
• Kevin Moran,
  VP of Investor Relations
• Patricia M. English,
  Sr. VP & Chief Accounting Officer
• Pamela O. Kimmet,
  Chief Human Resources Officer
• Michele Holcomb,
  EVP - Strategy & Corp. Dev.
• Falk T Stephen,
  EVP, Gen. Counsel & Corp. Sec.
• David P King,
  Director
• Craig S Morford,
  Chief Compliance Officer
• Colleen F. Arnold,
  Director
• Stuart G Laws,
  SVP & Chief Accounting Officer
• Donald M Jr. Casey,
  CEO, Medical Segment
• Clayton M Jones,
  Director
• David J Anderson,
  Director
• Patricia Morrison,
  Chief Information Officer
• Meghan Fitzgerald,
  EVP, Strategy & Health Policy
• Carole S Watkins,
  EVP - Human Resources
• Jon L Giacomin,
  CEO, Medical Segment
• George S Barrett,
  Chairman and CEO
• J Michael Losh,
  Director
• Deborah Weitzman,
  CEO, PSS Segment
• Jeffrey William Henderson,
  Executive Vice President
• David W Raisbeck,
  Director
• Michael A Lynch,
  CEO, Medical Segment
• Glenn Britt,
  Director
• Jean G Spaulding,
  Director
• John F Finn,
  Director
• Richard C Notebaert,
  Director
• Mark R Blake,
  EVP -- Strategy & Corp. Dev.
• James J Md Mongan,
  Director
• Jorge M Gomez,
  Chief Financial Officer
• Michael D Ohalleran,
  Director
• Vivek Jain,
  EVP - Corp Develop. & Strategy
• George H Conrades,
  Director
• Ivan K Fong,
  EVP, CLO & Secretary
• Robert D Walter,
  Chairman and CEO
• David L Schlotterbeck,
  Chmn & CEO-Clncl Techn & Svcs
• John B Mccoy,
  Director
• Philip L Francis,
  Director
• Matthew D Walter,
  Director
• R Kerry Clark,
  President and CEO
• Daniel J Walsh,
  EVP, Chf Ethcs & Compl Offcr
• Mark W Parrish,
  EVP; Group Pres.-Pharm. Distr.
• John F Havens,
  Director
• David Bing,
  Director
• Gary S Jensen,
  SVP - Corporate Controller
• Robert L Gerbig,
  Director
• Ronald K Labrum,
  CEO-Healthcare Supply Chn Svc
• Brendan A Ford,
  EVP - Corp. Development
• Anthony J Rucci,
  EVP & Chief Admin. Officer
• Joseph C Papa,
  Chmn & CEO, Pharm Techn & Svcs
• Stephen S Thomas,
  EVP-Group Pres.-AIS
• Gary D Dolch,
  EVP - Quality & Reg. Affairs
• George L Fotiades,
  President & COO
• Eric Slusser,
  SVP-Finance, CAO & Cntrllr
• Paul S Williams,
  EVP, CLO & Secretary
• Jody R Davids,
  EVP & CIO
• Richard J Miller,
  EVP & CFO
• Aaron E Alt,
  Chief Financial Officer
• Robert Azelby,
  Director
• Patricia M English,
  Chief Accounting Officer
• Christine Mundkur,
  Director
• Steven Barg,
  Director
• Michelle Brennan,
  Director
• Michelle D. Greene,
  Chief Information Officer
• Mary C. Scherer,
  Chief Accounting Officer